MTV, TLG AND SUV MAX AS PROMISING PARAMETERS TO PREDICT EARLY RESPONSE IN PATIENTS WITH HL TREATED WITH ABVD. A RETROSPECTIVE SUB‐ANALYSIS OF THE GATLA‐LH‐05 TRIAL.

Autor: Iorio, J., Eleta, M., Plates, V., Fiad, L., Riddick, M., Pavlovsky, A.
Zdroj: Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-2, 2p
Databáze: Complementary Index